Core Viewpoint - The article discusses a class action lawsuit against Charter Communications, alleging violations of the Securities Exchange Act of 1934 due to misleading statements and failure to disclose significant impacts on the company's performance related to the end of the Federal Communications Commission's Affordable Connectivity Program [1][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Sandoval v. Charter Communications, Inc., and it involves purchasers or acquirers of Charter Communications securities from July 26, 2024, to July 24, 2025 [1]. - Investors have until October 14, 2025, to seek appointment as lead plaintiff in the lawsuit [2][6]. - The lawsuit alleges that Charter Communications and its executives made false statements regarding the company's ability to manage the impact of the Affordable Connectivity Program's end, which affected customer retention and revenue [4]. Group 2: Financial Impact - On July 25, 2025, Charter Communications reported second quarter 2025 financial results, showing EBITDA of $5.7 billion, indicating a growth of 0.5% [5]. - The company experienced a decline of 117,000 Internet customers, with approximately 50,000 disconnects attributed to the end of the Affordable Connectivity Program [5]. - Following the financial results announcement, Charter Communications' stock price fell by more than 18% [5]. Group 3: Company Background - Charter Communications operates as a broadband connectivity and cable operator, serving both residential and commercial customers [3]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the investors, is recognized for its significant recoveries in securities fraud cases, having recovered over $2.5 billion for investors in 2024 alone [7].

Core Viewpoint - The article discusses a class action lawsuit against KinderCare Learning Companies, Inc. related to its October 2024 IPO, alleging violations of the Securities Act of 1933 due to misleading statements and undisclosed risks regarding child care quality and incidents of abuse [1][3]. Company Overview - KinderCare Learning Companies, Inc. provides early education and child care services in the United States [2]. - The company raised $648 million by selling over 27 million shares at $24 per share during its IPO [2]. Allegations of the Lawsuit - The lawsuit claims that the IPO registration statement was false and misleading, failing to disclose: - Numerous incidents of child abuse, neglect, and harm at KinderCare facilities [3]. - Inadequate care provided at its facilities, not meeting minimum standards in the child care industry [3]. - Exposure to material risks including lawsuits, regulatory actions, negative publicity, and reputational damage [3]. Stock Performance - Following the IPO, KinderCare's stock price fell to lows near $9 per share [4]. Legal Representation - The plaintiffs are represented by Robbins Geller Rudman & Dowd LLP, a law firm with extensive experience in prosecuting investor class actions [4].

Core Viewpoint - The law firm Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Fortinet, Inc. for alleged violations of the Securities Exchange Act of 1934, involving claims of misrepresentation regarding the company's product refresh cycle and its impact on business performance [1][3][4]. Group 1: Allegations of the Lawsuit - The lawsuit alleges that Fortinet's executives misrepresented the potential profitability of the product refresh cycle, claiming it would be lucrative despite it consisting of older products that represented a "small percentage" of the business [3]. - It is claimed that Fortinet did not have a clear understanding of the number of FortiGate firewalls eligible for upgrades, misleading investors about the refresh cycle's momentum [3][4]. - On August 6, 2025, Fortinet disclosed that it was "approximately 40% to 50% of the way through the 2026 upgrade cycle" by the end of Q2 2025, contradicting earlier statements and leading to a stock price drop of over 22% [4]. Group 2: Class Action Process - Investors who purchased Fortinet common stock during the specified class period (November 8, 2024, to August 6, 2025) have until November 21, 2025, to seek appointment as lead plaintiff in the lawsuit [1][5]. - The lead plaintiff will represent the interests of all class members and can select a law firm of their choice for litigation [5]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is recognized as a leading law firm in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has a strong track record, being ranked 1 in securing monetary relief for investors in securities class action cases for four out of the last five years [6].

Accessibility StatementSkip Navigation RADNOR, Pa., Sept. 28, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Charter Communications, Inc. ("Charter") (NASDAQ: CHTR) on behalf of those who purchased or otherwise acquired Charter securities, including purchasers of call options, or sellers of put options, between July 26, 2024, and July 24, 2025, inclusive (the "Class Period"). The lead pl ...

Group 1 - Coherent Corp. is under investigation by Pomerantz LLP for potential securities fraud or unlawful business practices involving its officers and/or directors [1] - On August 13, 2025, Coherent announced the sale of its Aerospace and Defense business to Advent for $400 million, with proceeds aimed at reducing debt [2] - Following the announcement of the sale, Coherent's stock price dropped by $22.36 per share, a decline of 19.61%, closing at $91.65 per share on August 14, 2025 [2]

Core Viewpoint - A class action lawsuit has been filed against Cytokinetics, alleging securities fraud and unlawful business practices related to the company's New Drug Application for aficamten [1]. Summary by Relevant Sections Class Action Details - Investors are encouraged to contact Pomerantz LLP to join the class action, with a deadline to appoint a Lead Plaintiff by November 17, 2025 [1]. - The lawsuit centers on whether Cytokinetics and its officers engaged in fraudulent activities concerning their securities [1]. FDA Interaction and Stock Impact - On March 10, 2025, Cytokinetics announced that the FDA would not hold an advisory committee meeting for aficamten's NDA [1]. - The FDA extended the action date for aficamten's NDA from September 26, 2025, to December 26, 2025, due to the need for a Risk Evaluation and Mitigation Strategy (REMS) that was not included in the original NDA [1]. - Following this announcement, Cytokinetics' stock price dropped by $5.57, or 12.98%, closing at $37.35 on May 2, 2025 [1]. - On May 6, 2025, CEO Robert I. Blum revealed that the company had multiple pre-NDA meetings with the FDA but chose to submit the NDA without a REMS, leading to a further stock price decline of $2.70, or 7.36%, closing at $33.97 [1].

Accessibility StatementSkip Navigation NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether DexCom and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the ...

Core Viewpoint - A lawsuit has been filed against Charter Communications, Inc. and certain senior executives for potential violations of federal securities laws, particularly related to the impact of the Affordable Connectivity Program's termination on the company's customer base and earnings [1][2]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of New York, captioned Sandoval v. Charter Communications, Inc., No. 1:25-cv-06747, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until October 14, 2025, to request to be appointed to lead the case [2]. Group 2: Company Background - Charter Communications is a leading broadband and cable operator that participated in the FCC's Affordable Connectivity Program (ACP), which provided funding to subsidize high-speed internet plans for low-income households [3]. - The ACP ended in June 2024 due to a lack of federal funding, leading to customer declines for Charter [3]. Group 3: Financial Impact - During the relevant period, Charter claimed to have successfully managed the risks associated with the end of the ACP, stating that the impact was behind them [4]. - However, the company continued to experience declines in internet customers and revenue, contradicting its earlier statements [4]. Group 4: Stock Performance - Following the announcement of its second quarter 2025 financial results on July 25, 2025, Charter reported a decrease of 117,000 total internet customers, including approximately 50,000 disconnects related to the end of the ACP, nearly double from the previous quarter [5]. - The stock price fell by $70.25 per share, or 18.4%, from $380.00 on July 24, 2025, to $309.75 on July 25, 2025, reflecting the negative market reaction to the news [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the upcoming lead plaintiff deadline on October 10, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased SelectQuote securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lead plaintiff must file a motion with the court by October 10, 2025, to represent other class members in the litigation [3]. Group 2: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements and failed to disclose critical information, including directing Medicare beneficiaries to plans that compensated SelectQuote rather than providing unbiased comparisons [5]. - It is claimed that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers, which resulted in non-compliance with laws and regulations [5]. - The lawsuit asserts that the misleading statements about SelectQuote's business operations led to investor damages when the true details became public [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and recovering over $438 million for investors in 2019 [4].

Group 1 - Halper Sadeh LLC is investigating STAAR Surgical Company for potential violations related to its sale to Alcon at $28.00 per share in cash [1] - CyberArk Software Ltd. is being investigated for its sale to Palo Alto Networks for $45.00 in cash and 2.2005 shares of Palo Alto common stock for each CyberArk share [2] - The firm may seek increased consideration for shareholders and additional disclosures regarding the proposed transactions [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no charge [4] - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [4]